Continuation of a randomized, double-blind, multicenter study of linezolid versus vancomycin in the treatment of patients with nosocomial pneumonia
- 1 March 2003
- journal article
- clinical trial
- Published by Elsevier in Clinical Therapeutics
- Vol. 25 (3) , 980-992
- https://doi.org/10.1016/s0149-2918(03)80118-2
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Vancomycin therapeutic drug monitoring: is there a consensus view? The results of a UK National External Quality Assessment Scheme (UK NEQAS) for Antibiotic Assays questionnaireJournal of Antimicrobial Chemotherapy, 2002
- Linezolid‐Induced Pure Red Blood Cell AplasiaClinical Infectious Diseases, 2002
- Thrombocytopenia Associated with Linezolid TherapyClinical Infectious Diseases, 2002
- Linezolid (PNU-100766) versus Vancomycin in the Treatment of Hospitalized Patients with Nosocomial Pneumonia: A Randomized, Double-Blind, Multicenter StudyClinical Infectious Diseases, 2001
- Nosocomial Infections in Combined Medical-Surgical Intensive Care Units in the United StatesInfection Control & Hospital Epidemiology, 2000
- Treatment of Gram-positive Nosocomial PneumoniaAmerican Journal of Respiratory and Critical Care Medicine, 2000
- Mortality Due to Ventilator-Associated Pneumonia or Colonization with Pseudomonas or Acinetobacter Species: Assessment by Quantitative Culture of Samples Obtained by a Protected Specimen BrushClinical Infectious Diseases, 1996
- The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory CommitteeJAMA, 1995
- Editorial: Monitoring Serum Vancomycin Levels: Climbing the Mountain Because It Is There?Clinical Infectious Diseases, 1994
- Mechanism of action and in vitro and in vivo activities of S-6123, a new oxazolidinone compoundAntimicrobial Agents and Chemotherapy, 1988